Withdrawn as duplicate: Evaluation of discharge prescribing after rescheduling of gabapentin as a controlled substance

Melody J Robbins; Catherine Floroff; Amanda Ingemi; Marcus C Kaplan

doi:10.1093/ajhp/zxab288

Withdrawn as duplicate: Evaluation of discharge prescribing after rescheduling of gabapentin as a controlled substance

Am J Health Syst Pharm. 2022 Apr 1;79(8):e97. doi: 10.1093/ajhp/zxab288.

Authors

Melody J Robbins^{1

2}, Catherine Floroff¹, Amanda Ingemi¹, Marcus C Kaplan¹

Affiliations

¹ Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA, USA.
² Department of Pharmacy, Chesapeake Regional Medical Center, Chesapeake, VA, USA.

Abstract

This article has been withdrawn due to a publisher error that caused the article to be duplicated. The definitive version of this article is published under DOI 10.1093/ajhp/zxab293.

MeSH terms

Analgesics, Opioid / therapeutic use
Controlled Substances*
Drug Prescriptions
Gabapentin
Humans
Hydrocodone
Patient Discharge*
Practice Patterns, Physicians'

Substances

Analgesics, Opioid
Controlled Substances
Gabapentin
Hydrocodone